PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Stanford researchers take a step toward developing a 'universal' flu vaccine

Targeting the stem rather than the head of a critical protein is the challenging but promising tactic of a new study

2013-12-17
(Press-News.org) Contact information: Tom Abate
tabate@stanford.edu
650-736-2245
Stanford School of Engineering
Stanford researchers take a step toward developing a 'universal' flu vaccine Targeting the stem rather than the head of a critical protein is the challenging but promising tactic of a new study

Every year the approach of flu season sets off a medical guessing game with life or death consequences. There are many different strains of flu and they vary from year to year. So each season authorities must make an educated guess and tell manufacturers which variants of the flu they should produce vaccines against.

Even when this system works, flu-related illnesses can kill 3,000 to 49,000 Americans annually, according to the Centers for Disease Control and Prevention. A bad guess or the unexpected emergence of a virulent strain could send the death toll higher.

Against this backdrop Stanford researchers report promising steps toward the creation of a universal flu vaccine, one that could be produced more quickly and offer broader protection than the virus-specific inoculants available today.

The researchers detail their work in the current edition of the Proceedings of the National Academy of Sciences. The team was led by chemical and bioengineer James R. Swartz, who is the James H. Clark Professor in the School of Engineering.

Their approach arises from a better understanding of the structure of a key protein on the surface of the flu virus, and a new process for making vaccines based on that understanding.

A flu virus is made up of different proteins. Protruding from the surface of the virus are hundreds of copies of a protein called Hemagglutinin (HA). Each copy of HA resembles a mushroom, with a head and a stem. The head of HA helps determine the virulence of a given strain of flu.

Today's vaccines are based on inactivated viruses that contain the heads of HA proteins. When a flu shot is injected into our blood stream, our immune system sees the HA head as a target, and creates antibodies to fight what appears to be an infection.

Teaching the immune system to recognize a target is the essence of vaccination. If we are exposed to the flu after getting vaccinated, our immune system is primed to recognize and eradicate the invading virus before it can replicate sufficient copies to make us sick.

Swartz and his colleagues base their new vaccine approach on the understanding that, whereas the head of the flu virus varies from year to year, the protein stem remains more constant over time.

Theoretically, a vaccine based on the stem should be more broadly protective against different strains of flu, and perhaps offer universal protection. Moreover, since the stem remains relatively constant from year to year, once our immune systems produces antibodies against that antigen, multi-season protection might be possible.

But this approach remains experimental and has not yet been tested on patients.

The Stanford paper focused on the first step in developing such a universal vaccine: creating a protein stem fragment that could be injected into the blood stream, in short, creating a target, or antigen, to attract the attention of our immune system and trigger an effective defense.

Yuan Lu, a postdoctoral scholar in Swartz's lab and member of the research team, outlined the process detailed in the PNAS paper.

The researchers began with a section of DNA that contained the instructions for making the protein structure for one important strain of flu, the H1N1 virus that caused the pandemic of 1918 and recurred in milder form in 2009.

The researchers started with the DNA sequence that defines the entire HA protein, both head and stem.

They then subtracted the DNA coding for the head. Thus, their edited DNA strand only contained the instructions for making the protein stem.

The Stanford team used a relatively new and experimental process to manufacture the viral stem. This process is called cell free protein synthesis (CFPS).

To understand how CFPS works let's review how proteins are made in nature.

Inside all cells there are molecular machines called RNA polymerases and ribosomes. These RNA polymerases and ribosomes "read" DNA to manufacture proteins based on the instructions in the genetic code.

In cell free protein synthesis, scientists bust open bacterial cells to create a molecular goop that contains a lot of these ribosomes. Scientists know how to transmit their DNA instructions directly to these protein factories.

The advantage of CFPS is that it can produce proteins in a few hours versus a couple of weeks or even a couple of months, which is how long it takes to make proteins for flu vaccines using the practices that are approved for medical use today.

The Stanford researchers used this CFPS process to create and refine a viral protein stem that would be useful as an experimental vaccine antigen.

To do this they had to solve two fundamental problems.

First, the CFPS process produced a single-strand protein, or monomer. But the HA stem is a trimer, or three identical monomers braided together.

Second, their bioengineered antigen was not initially soluble. In other words, it could not be made into a liquid vaccine form.

Remember that everything started with a DNA sequence. Making the antigen involved feeding a DNA sequence into the molecular goop containing RNA polymerases and ribosomes, extracting the viral protein stems, and determining whether they had created soluble trimers that had at least the potential to be injectable antigens.

The researchers went though dozens of experiments to produce monomers that could fold into soluble trimers. Proteins are made of smaller building blocks called amino acids. Changing the structure of the protein stem therefore involved editing the DNA to change specific amino acids, running these new instructions back through the ribosome factories, extracting the finished product and testing the results.

It took dozens of tries over two years but eventually the researchers fed a DNA snippet into the CFPS process and created a soluble viral stem protein that could be a good antigen. That is what they report in the PNAS paper.

"This has been a tough process," Swartz said. "Many labs have been trying to develop an HA stem vaccine and we're glad to have made these contributions."

Many steps remain before the research community knows whether this viral stem approach yields a better flu vaccine. Next, Swartz and his team will attach their stem protein to a virus-like particle. The idea will be to create a bigger, better target with which to elicit an immune system response.

Should that prove successful, the new vaccine candidate would have to undergo safety and efficacy tests in animals, and eventually, large scale human clinical trials.

Much is at stake. Recent estimates put the worldwide death toll from flu-related illnesses at between 250,000 and 500,000 persons per year.

"This is an important project for world health," Swartz said, noting that the vaccine must not only be broadly effective against different strains of flu but cheap to produce so that it can be widely distributed. "These are big challenges but we are committed to the effort."



INFORMATION:

Media contact:
Tom Abate, Associate Director of Communications, Stanford Engineering
650-736-2245, tabate@stanford



ELSE PRESS RELEASES FROM THIS DATE:

Minorities' health would benefit most from beverage sugar tax, UCSF researchers report

2013-12-17
Minorities' health would benefit most from beverage sugar tax, UCSF researchers report Taxing sugar-sweetened beverages is likely to decrease consumption, resulting in lower rates of diabetes and heart disease, and these health benefits are ...

'Automation addiction,' other airline flight issues could be mitigated by better user interface

2013-12-17
'Automation addiction,' other airline flight issues could be mitigated by better user interface Human factors/ergonomics experts conceptualize UI improvements that might prevent tragedy Amid news reports on the National Transportation Safety Board hearings regarding ...

Regenerative medicine: Mayo Clinic and collaborators develop new tool for transplanting stem cells

2013-12-17
Regenerative medicine: Mayo Clinic and collaborators develop new tool for transplanting stem cells ROCHESTER, Minn. -- Mayo Clinic researchers and colleagues in Belgium have developed a specialized catheter for transplanting stem cells into the beating heart. The novel ...

Chicago scientist involved in discovery of 4 new mammal species in Democratic Republic of Congo

2013-12-17
Chicago scientist involved in discovery of 4 new mammal species in Democratic Republic of Congo CHICAGO -- Julian Kerbis Peterhans, a Roosevelt University professor and adjunct curator at The Field Museum who has conducted extensive studies on mammals in Africa, has announced ...

Brain chemical ratios help predict developmental delays in preterm infants

2013-12-17
Brain chemical ratios help predict developmental delays in preterm infants OAK BROOK, Ill. – Researchers have identified a potential biomarker for predicting whether a premature infant is at high risk for motor development problems, according to a ...

Contrast agent linked with brain abnormalities on MRI

2013-12-17
Contrast agent linked with brain abnormalities on MRI OAK BROOK, Ill. – For the first time, researchers have confirmed an association between a common magnetic resonance imaging (MRI) contrast agent and abnormalities on brain MRI, according to a new ...

Pain drugs used in prostate gland removal linked to cancer outcome, Mayo Clinic-led study finds

2013-12-17
Pain drugs used in prostate gland removal linked to cancer outcome, Mayo Clinic-led study finds Research examines link between opioid suppression of immune system and cancer recurrence ROCHESTER, Minn -- The methods used to anesthetize prostate cancer patients and control ...

Ancestor of snakes, lizards likely gave birth to live young

2013-12-17
Ancestor of snakes, lizards likely gave birth to live young Controversial finding changes previous belief that ancestor laid eggs WASHINGTON—The ancestor of snakes and lizards likely gave birth to live young, rather than laid eggs, and over time species have ...

Self-worth boosts ability to overcome poverty

2013-12-17
Self-worth boosts ability to overcome poverty For people in poverty, remembering better times – such as past success – improves brain functioning by several IQ points and increases their willingness to seek help from crucial aid services, a new study finds. The ...

UT Arlington marketing study shows ethnically diverse workforce may improve customer experience

2013-12-16
UT Arlington marketing study shows ethnically diverse workforce may improve customer experience Future of business depends on diversity Service-oriented businesses that want to succeed with minority customers should consider hiring frontline employees who represent ...

LAST 30 PRESS RELEASES:

Exercise as an anti-ageing intervention to avoid detrimental impact of mental fatigue

UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’

New guidelines aim to improve cystic fibrosis screening

Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

CCNY physicists uncover electronic interactions mediated via spin waves

Researchers’ 3D-printing formula may transform future of foam

Nurture more important than nature for robotic hand

Drug-delivering aptamers target leukemia stem cells for one-two knockout punch

New study finds that over 95% of sponsored influencer posts on Twitter were not disclosed

New sea grant report helps great lakes fish farmers navigate aquaculture regulations

Strain “trick” improves perovskite solar cells’ efficiency

How GPS helps older drivers stay on the roads

Estrogen and progesterone stimulate the body to make opioids

Dancing with the cells – how acoustically levitating a diamond led to a breakthrough in biotech automation

Machine learning helps construct an evolutionary timeline of bacteria

Cellular regulator of mRNA vaccine revealed... offering new therapeutic options

Animal behavioral diversity at risk in the face of declining biodiversity

Finding their way: GPS ignites independence in older adult drivers

Antibiotic resistance among key bacterial species plateaus over time

‘Some insects are declining but what’s happening to the other 99%?’

Powerful new software platform could reshape biomedical research by making data analysis more accessible

Revealing capillaries and cells in living organs with ultrasound

American College of Physicians awards $260,000 in grants to address equity challenges in obesity care

Researchers from MARE ULisboa discover that the European catfish, an invasive species in Portugal, has a prolonged breeding season, enhancing its invasive potential

Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research

Solar cells made of moon dust could power future space exploration

Deporting immigrants may further shrink the health care workforce

Border region emergency medical services in migrant emergency care

Resident physician intentions regarding unionization

[Press-News.org] Stanford researchers take a step toward developing a 'universal' flu vaccine
Targeting the stem rather than the head of a critical protein is the challenging but promising tactic of a new study